University of California, Los Angeles About Us   |   Diversity and Inclusion  |   Contact Us   |   Campus Directory   |   Giving   |   Maps/Directions

Judy Gasson, Ph.D.

Contact Information:

Work Phone Number:

(310) 825-5268

Laboratory Address:

Laboratory
700 Tiverton Ave
Factor 11-151
Los Angeles, CA 90095
UNITED STATES

Office Address:

Office
700 Tiverton Ave
Factor 8-684
Los Angeles, CA 90095
UNITED STATES

Work Email Address:

jgasson@mednet.ucla.edu

Websites:

  

Home Page:

     Home Page
     Web-Profile
     Jonsson Cancer Center - Information by Judith Gasson


Senior Associate Dean for Research, David Geffen School of Medicine at UCLA

Professor, Biological Chemistry

Department of Medicine

Director, Jonsson Comprehensive Cancer Center

Associate Director, CTSI

Co-Director, Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research


A Short Biography:

Judith C. Gasson, a professor of biological chemistry and medicine, became director of UCLA?s Jonsson Comprehensive Cancer Center on Sept. 15, 1995. A molecular biologist, Gasson is responsible for one of only 39 institutions nationwide designated as comprehensive cancer centers by the National Cancer Institute. In addition to her administrative duties, Gasson also is a gifted scientist. She was instrumental in purifying for the first time a hormone-like substance that increases the speed of bone marrow cell reproduction. That substance, called GM-CSF, is used to help prevent infections in cancer patients, and to allow patients to tolerate more chemotherapy and radiation than had previously been possible. In 2005, Gasson was named a co-director of the UCLA Institute of Stem Cell Biology and Medicine and she recently testified before a key Senate subcommittee on the promise of stem cell research in cancer. Gasson also serves as a board member for the American Association for Cancer Research. She earned a bachelor?s degree in microbiology from Colorado State University and a doctorate in physiology at the University of Colorado. Gasson did post doctoral work at the Salk Institute in La Jolla. In 1983, she left the Salk Institute to join UCLA's Jonsson Cancer Center, which comprises more than 240 researchers and clinicians engaged in research, prevention, detection, control, treatment and education. One of the nation's largest comprehensive cancer centers, the Jonsson center is dedicated to promoting research and translating the results into leading-edge clinical studies. In July 2005, the Jonsson Cancer Center was named the best cancer center in the western United States by U.S. News & World Report, a ranking it has held for six consecutive years.

Awards and Honors:

Stohlman Memorial Scholar Award, Leukemia Society of America
UCLA "Woman of Science"
Inducted into Glover Gallery, Colorado State University
Recipient, Leukemia Society of America Scholar Award
Richard F. Dwyer-Eleanor W. Dwyer Fund for Excellence at the Jonsson Comprehensive Cancer Center
Recipient, American Cancer Society Junior Faculty Award

Research Interest:

Molecular Physiology of Human Blood Cell Production

Judy Gasson is a professor of Medicine (Hem-Onc) and Biological Chemistry and the director of UCLA?s Jonsson Comprehensive Cancer Center. Her laboratory studies the molecular events that regulate proliferation and differentiation in mouse and human blood cell (hematopoietic) progenitor cells. When these processes become unregulated leukemias and other diseases can result. In the mid-1980s she and her collaborators purified the human Granulocyte-Macrophage Colony-Stimulating-Factor (GM-CSF) and defined many of its biological activities; it was subsequently used to treat patients recovering from bone marrow transplantation. Her current activities are focused upon in vitro model systems that are designed to better understand the interactions between blood cell progenitor cells and the stroma cells necessary for their proliferation and differentiation in the bone marrow.


Detailed Biography:

Judith Gasson, Ph.D., became the director of UCLA's Jonsson Comprehensive Cancer Center (JCCC) on Sept. 15, 1995. She is a molecular biologist and is responsible for one of only 40 institutions designated as comprehensive cancer centers by the National Cancer Institute. Gasson earned her doctorate degree in physiology at the University of Colorado in 1979. She did her postdoctoral work at the Salk Institute in La Jolla, CA, studying glucocorticoid hormones, which are made by the adrenal gland in response to stress. In 1983, she left the Salk Institute to join JCCC. Gasson was instrumental in purifying for the first time a hormone-like substance that increases the speed of bone marrow cell reproduction. That substance, called GM-CSF, is used to help prevent infections in cancer patients and to allow those patients to tolerate more chemotherapy and radiation than had previously been possible. For the past fifteen years, Dr. Gasson has been the director of UCLA?s Jonsson Comprehensive Cancer Center (JCCC), among the nation?s top 10, according to U.S. News & World Report. Under her leadership, the JCCC has become a recognized international pioneer in ?translating? laboratory discoveries into more effective new therapies for cancer patients everywhere.

Publications:

Hamidi Habib, Gustafason Derek, Pellegrini Matteo, Gasson Judith   Identification of novel targets of CSL-dependent Notch signaling in hematopoiesis PloS one, 2011; 6(5): e20022.
Lynch Maureen R, Gasson Judith C, Paz Helicia   Modified ES / OP9 co-culture protocol provides enhanced characterization of hematopoietic progeny Journal of visualized experiments : JoVE, 2011; 10(52): .
Zhu Min, Saxton Romaine E, Ramos Lillian, Chang David D, Karlan Beth Y, Gasson Judith C, Slamon Dennis J   Neutralizing monoclonal antibody to periostin inhibits ovarian tumor growth and metastasis Molecular cancer therapeutics, 2011; 10(8): 1500-8.
Zhu Min, Fejzo Marlena S, Anderson Lee, Dering Judy, Ginther Charles, Ramos Lillian, Gasson Judith C, Karlan Beth Y, Slamon Dennis J   Periostin promotes ovarian cancer angiogenesis and metastasis Gynecologic oncology, 2010; 119(2): 337-44.
Paz Helicia, Lynch Maureen R, Bogue Clifford W, Gasson Judith C   The homeobox gene Hhex regulates the earliest stages of definitive hematopoiesis Blood, 2010; 116(8): 1254-62.
Zovein Ann C, Turlo Kirsten A, Ponec Ryan M, Lynch Maureen R, Chen Kevin C, Hofmann Jennifer J, Cox Timothy C, Gasson Judith C, Iruela-Arispe M Luisa   Vascular remodeling of the vitelline artery initiates extravascular emergence of hematopoietic clusters Blood, 2010; 116(18): 3435-44.
Zovein Ann C, Hofmann Jennifer J, Lynch Maureen, French Wendy J, Turlo Kirsten A, Yang Yanan, Becker Michael S, Zanetta Lucia, Dejana Elisabetta, Gasson Judith C, Tallquist Michelle D, Iruela-Arispe M Luisa   Fate tracing reveals the endothelial origin of hematopoietic stem cells Cell stem cell, 2008; 3(6): 625-36.
Rubin Ethel, Wu Xinyan, Zhu Tao, Cheung Joyce C Y, Chen Hexin, Lorincz Annaka, Pandita Raj K, Sharma Girdhar G, Ha Hyo Chol, Gasson Judith, Hanakahi Les A, Pandita Tej K, Sukumar Saraswati   A role for the HOXB7 homeodomain protein in DNA repair Cancer research, 2007; 67(4): 1527-35.
Ganapati Uma, Tan Hongying Tina, Lynch Maureen, Dolezal Milana, de Vos Sven, Gasson Judith C   Modeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression Stem cells (Dayton, Ohio), 2007; 25(8): 1872-80.
Carlson Anne, Berkowitz Jeanne McAdara, Browning Damaris, Slamon Dennis J, Gasson Judith C, Yates Karen E   Expression of c-Fes protein isoforms correlates with differentiation in myeloid leukemias DNA and cell biology, 2005; 24(5): 311-6.
Carlson Anne, Yates Karen E, Slamon Dennis J, Gasson Judith C   Spatial and temporal changes in the subcellular localization of the nuclear protein-tyrosine kinase, c-Fes DNA and cell biology, 2005; 24(4): 225-34.
Gasson Judith C   Why cancer centers matter Cancer biology & therapy, 2005; 4(4): 493-5.
Yaron Y, McAdara J K, Lynch M, Hughes E, Gasson J C   Identification of novel functional regions important for the activity of HOXB7 in mammalian cells Journal of immunology (Baltimore, Md. : 1950), 2001; 166(8): 5058-67.
Walker L, Carlson A, Tan-Pertel H T, Weinmaster G, Gasson J   The notch receptor and its ligands are selectively expressed during hematopoietic development in the mouse Stem cells (Dayton, Ohio), 2001; 19(6): 543-52.
Villa N, Walker L, Lindsell C E, Gasson J, Iruela-Arispe M L, Weinmaster G   Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels Mechanisms of development, 2001; 108(1-2): 161-4.
Ismail R S, Baldwin R L, Fang J, Browning D, Karlan B Y, Gasson J C, Chang D D   Differential gene expression between normal and tumor-derived ovarian epithelial cells Cancer research, 2000; 60(23): 6744-9.
Tan-Pertel H T, Walker L, Browning D, Miyamoto A, Weinmaster G, Gasson J C   Notch signaling enhances survival and alters differentiation of 32D myeloblasts Journal of immunology (Baltimore, Md. : 1950), 2000; 165(8): 4428-36.
Fuller J F, McAdara J, Yaron Y, Sakaguchi M, Fraser J K, Gasson J C   Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation Blood, 1999; 93(10): 3391-400.
Crooks G M, Fuller J, Petersen D, Izadi P, Malik P, Pattengale P K, Kohn D B, Gasson J C   Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors Blood, 1999; 94(2): 519-28.
Walker L, Lynch M, Silverman S, Fraser J, Boulter J, Weinmaster G, Gasson J C   The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro Stem cells (Dayton, Ohio), 1999; 17(3): 162-71.
Yates K E, Crooks G M, Gasson J C   Analysis of Fes kinase activity in myeloid cell growth and differentiation Stem cells (Dayton, Ohio), 1996; 14(6): 714-24.
Yates K E, Gasson J C   Role of c-Fes in normal and neoplastic hematopoiesis Stem cells (Dayton, Ohio), 1996; 14(1): 117-23.
Ronco L V, Doyle S E, Raines M, Park L S, Gasson J C   Conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor-binding subunit essential for tyrosine phosphorylation and proliferation Journal of immunology (Baltimore, Md. : 1950), 1995; 154(7): 3444-53.
Yates K E, Lynch M R, Wong S G, Slamon D J, Gasson J C   Human c-FES is a nuclear tyrosine kinase Oncogene, 1995; 10(6): 1239-42.
Lill M C, Fuller J F, Herzig R, Crooks G M, Gasson J C   The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation Blood, 1995; 85(3): 692-7.
Rosenblatt J D, Miles S, Gasson J C, Prager D   Transactivation of cellular genes by human retroviruses Current topics in microbiology and immunology, 1995; 193(3): 25-49.
Fraser J K, Guerra J J, Nguyen C Y, Indes J E, Gasson J C, Nimer S D   Characterization of a cell-type-restricted negative regulatory activity of the human granulocyte-macrophage colony-stimulating factor gene Molecular and cellular biology, 1994; 14(3): 2213-21.
Sakamoto K M, Fraser J K, Lee H J, Lehman E, Gasson J C   Granulocyte-macrophage colony-stimulating factor and interleukin-3 signaling pathways converge on the CREB-binding site in the human egr-1 promoter Molecular and cellular biology, 1994; 14(9): 5975-85.
Lill M C, Lynch M, Fraser J K, Chung G Y, Schiller G, Glaspy J A, Souza L, Baldwin G C, Gasson J C   Production of functional myeloid cells from CD34-selected hematopoietic progenitor cells using a clinically relevant ex vivo expansion system Stem cells (Dayton, Ohio), 1994; 12(6): 626-37.
Sakamoto K M, Mignacca R C, Gasson J C   Signal transduction by granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors Receptors & channels, 1994; 2(3): 175-81.
Baldwin G C, Benveniste E N, Chung G Y, Gasson J C, Golde D W   Identification and characterization of a high-affinity granulocyte-macrophage colony-stimulating factor receptor on primary rat oligodendrocytes Blood, 1993; 82(11): 3279-82.
Liesveld J L, Rush S, Kempski M C, Turner A R, Brennan J K, Gasson J C, Abboud C N   Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire Experimental hematology, 1993; 21(10): 1342-52.
Sakamoto K M, Nimer S D, Rosenblatt J D, Gasson J C   HTLV-I and HTLV-II tax trans-activate the human EGR-1 promoter through different cis-acting sequences Oncogene, 1992; 7(11): 2125-30.
Sakamoto K M, Bardeleben C, Yates K E, Raines M A, Golde D W, Gasson J C   5' upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8 Oncogene, 1991; 6(5): 867-71.
DiPersio J F, Hedvat C, Ford C F, Golde D W, Gasson J C   Characterization of the soluble human granulocyte-macrophage colony-stimulating factor receptor complex The Journal of biological chemistry, 1991; 266(1): 279-86.
Sakamoto K M, Gasson J C   Clinical applications of human granulocyte-macrophage colony-stimulating factor International journal of cell cloning, 1991; 9(6): 531-41.
Sakamoto K M, Golde D W, Gasson J C   The biology and clinical applications of granulocyte-macrophage colony-stimulating factor The Journal of pediatrics, 1991; 118(3): S17-20.
Avalos B R, Gasson J C, Hedvat C, Quan S G, Baldwin G C, Weisbart R H, Williams R E, Golde D W, DiPersio J F   Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines Blood, 1990; 75(4): 851-7.
Gasson J C, Fraser J K, Nimer S D   Human granulocyte-macrophage colony-stimulating factor (GM-CSF): regulation of expression Progress in clinical and biological research, 1990; 338(4): 27-41.
Niskanen E, Gasson J C, Egrie J, Wipf K, Golde D W   Recombinant human erythroid potentiating activity enhances the effect of erythropoietin in mice European journal of haematology, 1990; 45(5): 267-70.
Gasson J C, Baldwin G C, Sakamoto K M, DiPersio J F   The biology of human granulocyte-macrophage colony-stimulating factor (GM-CSF) Progress in clinical and biological research, 1990; 352(4): 375-84.
Nimer S D, Gasson J C, Hu K, Smalberg I, Williams J L, Chen I S, Rosenblatt J D   Activation of the GM-CSF promoter by HTLV-I and -II tax proteins Oncogene, 1989; 4(6): 671-6.
Weisbart R H, Gasson J C, Golde D W   Colony-stimulating factors and host defense Annals of internal medicine, 1989; 110(4): 297-303.
Kaufman S E, DiPersio J F, Gasson J C   Effects of human GM-CSF on neutrophil degranulation in vitro Experimental hematology, 1989; 17(7): 800-4.
Economou J S, Rhoades K, Essner R, McBride W H, Gasson J C, Morton D L   Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line The Journal of experimental medicine, 1989; 170(1): 321-6.
Varnum B C, Lim R W, Kujubu D A, Luner S J, Kaufman S E, Greenberger J S, Gasson J C, Herschman H R   Granulocyte-macrophage colony-stimulating factor and tetradecanoyl phorbol acetate induce a distinct, restricted subset of primary-response TIS genes in both proliferating and terminally differentiated myeloid cells Molecular and cellular biology, 1989; 9(8): 3580-3.
Nimer S D, Gates M J, Koeffler H P, Gasson J C   Multiple mechanisms control the expression of granulocyte-macrophage colony-stimulating factor by human fibroblasts Journal of immunology (Baltimore, Md. : 1950), 1989; 143(7): 2374-7.
Baldwin G C, Gasson J C, Kaufman S E, Quan S G, Williams R E, Avalos B R, Gazdar A F, Golde D W, DiPersio J F   Nonhematopoietic tumor cells express functional GM-CSF receptors Blood, 1989; 73(4): 1033-7.
Nimer S D, Morita E A, Martis M J, Wachsman W, Gasson J C   Characterization of the human granulocyte-macrophage colony-stimulating factor promoter region by genetic analysis: correlation with DNase I footprinting Molecular and cellular biology, 1988; 8(5): 1979-84.
DiPersio J, Billing P, Kaufman S, Eghtesady P, Williams R E, Gasson J C   Characterization of the human granulocyte-macrophage colony-stimulating factor receptor The Journal of biological chemistry, 1988; 263(4): 1834-41.
DiPersio J F, Naccache P H, Borgeat P, Gasson J C, Nguyen M H, McColl S R   Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis Prostaglandins, 1988; 36(5): 673-91.
Koyanagi Y, O'Brien W A, Zhao J Q, Golde D W, Gasson J C, Chen I S   Cytokines alter production of HIV-1 from primary mononuclear phagocytes Science (New York, N.Y.), 1988; 241(4873): 1673-5.
Baldwin G C, Gasson J C, Quan S G, Fleischmann J, Weisbart R, Oette D, Mitsuyasu R T, Golde D W   Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients Proceedings of the National Academy of Sciences of the United States of America, 1988; 85(8): 2763-6.
Naccache P H, Faucher N, Borgeat P, Gasson J C, DiPersio J F   Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils Journal of immunology (Baltimore, Md. : 1950), 1988; 140(10): 3541-6.
Golde D W, Gasson J C   Hormones that stimulate the growth of blood cells Scientific American, 1988; 259(1): 62-71.
DiPersio J F, Billing P, Williams R, Gasson J C   Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis Journal of immunology (Baltimore, Md. : 1950), 1988; 140(12): 4315-22.
Niskanen E, Gasson J C, Teates C D, Golde D W   In vivo effect of human erythroid-potentiating activity on hematopoiesis in mice Blood, 1988; 72(2): 806-10.
Avalos B R, Kaufman S E, Tomonaga M, Williams R E, Golde D W, Gasson J C   K562 cells produce and respond to human erythroid-potentiating activity Blood, 1988; 71(6): 1720-5.
Benveniste E N, Tozawa H, Gasson J C, Quan S, Golde D W, Merrill J E   Response of human glioblastoma cells to recombinant interleukin-2 Journal of neuroimmunology, 1988; 17(4): 301-14.
Nimer S D, Gasson J C, DiPersio J F   The expression and target cell specificity of human granulocyte-macrophage colony-stimulating factor The Year in immunology, 1988; 3(4): 144-51.
Strife A, Lambek C, Wisniewski D, Gulati S, Gasson J C, Golde D W, Welte K, Gabrilove J L, Clarkson B   Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells Blood, 1987; 69(5): 1508-23.
Owen W F, Rothenberg M E, Silberstein D S, Gasson J C, Stevens R L, Austen K F, Soberman R J   Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts The Journal of experimental medicine, 1987; 166(1): 129-41.
Rosenblatt J D, Gasson J C, Glaspy J, Bhuta S, Aboud M, Chen I S, Golde D W   Relationship between human T cell leukemia virus-II and atypical hairy cell leukemia: a serologic study of hairy cell leukemia patients Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 1987; 1(4): 397-401.
Rosenblatt J D, Golde D W, Wachsman W, Giorgi J V, Jacobs A, Schmidt G M, Quan S, Gasson J C, Chen I S   A second isolate of HTLV-II associated with atypical hairy-cell leukemia The New England journal of medicine, 1986; 315(6): 372-7.
Weisbart R H, Golde D W, Gasson J C   Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors Journal of immunology (Baltimore, Md. : 1950), 1986; 137(11): 3584-7.
Silberstein D S, Owen W F, Gasson J C, DiPersio J F, Golde D W, Bina J C, Soberman R, Austen K F, David J R   Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor Journal of immunology (Baltimore, Md. : 1950), 1986; 137(10): 3290-4.
Le Beau M M, Westbrook C A, Diaz M O, Larson R A, Rowley J D, Gasson J C, Golde D W, Sherr C J   Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders Science (New York, N.Y.), 1986; 231(4741): 984-7.
Fleischmann J, Golde D W, Weisbart R H, Gasson J C   Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils Blood, 1986; 68(3): 708-11.
Gasson J C, Kaufman S E, Weisbart R H, Tomonaga M, Golde D W   High-affinity binding of granulocyte-macrophage colony-stimulating factor to normal and leukemic human myeloid cells Proceedings of the National Academy of Sciences of the United States of America, 1986; 83(3): 669-73.
Huebner K, Isobe M, Gasson J C, Golde D W, Croce C M   Localization of the gene encoding human erythroid-potentiating activity to chromosome region Xp11.1----Xp11.4 American journal of human genetics, 1986; 38(6): 819-26.
Chan J Y, Slamon D J, Nimer S D, Golde D W, Gasson J C   Regulation of expression of human granulocyte/macrophage colony-stimulating factor Proceedings of the National Academy of Sciences of the United States of America, 1986; 83(22): 8669-73.
Gasson J C, Golde D W, Weisbart R H   Biological activities of human granulocyte-macrophage colony-stimulating factor The Year in immunology, 1985; 184(6009): 118-21.
Gasson J C, Bersch N, Golde D W   Characterization of purified human erythroid-potentiating activity Progress in clinical and biological research, 1985; 184(6009): 95-104.
Weisbart R H, Golde D W, Clark S C, Wong G G, Gasson J C   Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator Nature, 1985; 314(6009): 361-3.
Gasson J C, Golde D W, Kaufman S E, Westbrook C A, Hewick R M, Kaufman R J, Wong G G, Temple P A, Leary A C, Brown E L   Molecular characterization and expression of the gene encoding human erythroid-potentiating activity Nature, 1985; 315(6022): 768-71.
Benveniste E N, Merrill J E, Kaufman S E, Golde D W, Gasson J C   Purification and characterization of a human T-lymphocyte-derived glial growth-promoting factor Proceedings of the National Academy of Sciences of the United States of America, 1985; 82(11): 3930-4.
Slamon D J, Press M F, Souza L M, Murdock D C, Cline M J, Golde D W, Gasson J C, Chen I S   Studies of the putative transforming protein of the type I human T-cell leukemia virus Science (New York, N.Y.), 1985; 228(4706): 1427-30.
Huebner K, Isobe M, Croce C M, Golde D W, Kaufman S E, Gasson J C   The human gene encoding GM-CSF is at 5q21-q32, the chromosome region deleted in the 5q- anomaly Science (New York, N.Y.), 1985; 230(4731): 1282-5.
Chen I S, McLaughlin J, Gasson J C, Clark S C, Golde D W   Molecular characterization of genome of a novel human T-cell leukaemia virus Nature, 1984; 305(5934): 502-5.
Westbrook C A, Gasson J C, Gerber S E, Selsted M E, Golde D W   Purification and characterization of human T-lymphocyte-derived erythroid-potentiating activity The Journal of biological chemistry, 1984; 259(16): 9992-6.
Gasson J C, Weisbart R H, Kaufman S E, Clark S C, Hewick R M, Wong G G, Golde D W   Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils Science (New York, N.Y.), 1984; 226(4680): 1339-42.
Gasson J C, Bourgeois S   A new determinant of glucocorticoid sensitivity in lymphoid cell lines The Journal of cell biology, 1983; 96(2): 409-15.
Gasson J C, Ryden T, Bourgeois S   Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line Nature, 1983; 302(5909): 621-3.
Huet-Minkowski M, Gasson J C, Bourgeois S   Induction of glucocorticoid-resistant variants in a murine thymoma line by antitumor drugs Cancer research, 1981; 41(11 Pt 1): 4540-6.
Gasson J C   Steroidogenic activity of high molecular weight forms of corticotropin Biochemistry, 1979; 18(19): 4215-24.
UCLA    |    Terms & Conditions    |    Disability Resources    |    UC Regents